Average Co-Inventor Count = 6.92
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Elan Pharmaceuticals, Inc. (47 from 202 patents)
2. Other (26 from 832,680 patents)
3. Wyeth (22 from 1,309 patents)
4. Ingenium Pharmaceuticals Gmbh (5 from 6 patents)
5. University of California (2 from 15,458 patents)
6. Eli Lilly and Company (2 from 4,442 patents)
7. Athena Neurosciences, Inc. (2 from 35 patents)
8. Astrazeneca Ab (1 from 1,500 patents)
9. The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone (1 from 19 patents)
10. The J. David Gladstone Institutes, a Testimentary Trust Established Under the Will of J. David Gladstone (1 from 1 patent)
86 patents:
1. 10611741 - Substituted benzoxazine and related compounds
2. 10087151 - Substituted benzoxazine and related compounds
3. 9376423 - PKC-epsilon inhibitors
4. 8841315 - Inhibitors of protein kinases
5. 8785648 - PKC-epsilon inhibitors
6. 8716296 - Inhibitors of protein kinases
7. 8507498 - 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
8. 8507511 - Inhibitors of protein kinases
9. 8436007 - Inhibitors of protein kinases
10. 8389521 - Inhibitors of protein kinases
11. 8263063 - Multimeric VLA-4 antagonists comprising polymer moieties
12. 7973044 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
13. 7968547 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
14. 7794700 - Multimeric VLA-4 antagonists comprising polymer moieties
15. 7759382 - Acylated amino acid amidyl pyrazoles and related compounds